Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: E9AZM8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 105 | 109 | PF00656 | 0.601 |
CLV_C14_Caspase3-7 | 111 | 115 | PF00656 | 0.729 |
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.704 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.639 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.613 |
CLV_PCSK_PC1ET2_1 | 142 | 144 | PF00082 | 0.538 |
CLV_PCSK_PC7_1 | 208 | 214 | PF00082 | 0.580 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.725 |
CLV_PCSK_SKI1_1 | 256 | 260 | PF00082 | 0.382 |
DOC_CYCLIN_yCln2_LP_2 | 331 | 337 | PF00134 | 0.475 |
DOC_MAPK_MEF2A_6 | 327 | 335 | PF00069 | 0.422 |
DOC_PP1_RVXF_1 | 336 | 343 | PF00149 | 0.574 |
DOC_PP2B_LxvP_1 | 235 | 238 | PF13499 | 0.486 |
DOC_PP2B_LxvP_1 | 331 | 334 | PF13499 | 0.489 |
DOC_PP4_FxxP_1 | 21 | 24 | PF00568 | 0.346 |
DOC_PP4_FxxP_1 | 295 | 298 | PF00568 | 0.505 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.480 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.495 |
DOC_WW_Pin1_4 | 241 | 246 | PF00397 | 0.568 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.692 |
LIG_14-3-3_CanoR_1 | 143 | 149 | PF00244 | 0.513 |
LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.647 |
LIG_14-3-3_CanoR_1 | 82 | 92 | PF00244 | 0.461 |
LIG_Actin_WH2_2 | 159 | 177 | PF00022 | 0.459 |
LIG_Actin_WH2_2 | 247 | 262 | PF00022 | 0.428 |
LIG_BIR_III_2 | 69 | 73 | PF00653 | 0.423 |
LIG_CaM_IQ_9 | 268 | 283 | PF13499 | 0.496 |
LIG_eIF4E_1 | 263 | 269 | PF01652 | 0.382 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.525 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.496 |
LIG_FHA_2 | 242 | 248 | PF00498 | 0.514 |
LIG_FHA_2 | 272 | 278 | PF00498 | 0.585 |
LIG_GBD_Chelix_1 | 170 | 178 | PF00786 | 0.476 |
LIG_LIR_Apic_2 | 20 | 24 | PF02991 | 0.342 |
LIG_LIR_Apic_2 | 292 | 298 | PF02991 | 0.548 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.578 |
LIG_LIR_Nem_3 | 129 | 134 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 14 | 19 | PF02991 | 0.509 |
LIG_LIR_Nem_3 | 247 | 251 | PF02991 | 0.560 |
LIG_LIR_Nem_3 | 346 | 352 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 355 | 359 | PF02991 | 0.479 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.465 |
LIG_PTB_Apo_2 | 133 | 140 | PF02174 | 0.555 |
LIG_REV1ctd_RIR_1 | 129 | 139 | PF16727 | 0.451 |
LIG_SH2_CRK | 189 | 193 | PF00017 | 0.477 |
LIG_SH2_SRC | 189 | 192 | PF00017 | 0.474 |
LIG_SH2_STAP1 | 263 | 267 | PF00017 | 0.436 |
LIG_SH2_STAT3 | 138 | 141 | PF00017 | 0.382 |
LIG_SH2_STAT3 | 38 | 41 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 352 | 355 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.489 |
LIG_SH3_1 | 351 | 357 | PF00018 | 0.550 |
LIG_SH3_3 | 181 | 187 | PF00018 | 0.478 |
LIG_SH3_3 | 351 | 357 | PF00018 | 0.612 |
LIG_TRFH_1 | 295 | 299 | PF08558 | 0.495 |
LIG_TRFH_1 | 58 | 62 | PF08558 | 0.487 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.558 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.605 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.527 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.657 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.747 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.431 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.473 |
MOD_GlcNHglycan | 247 | 251 | PF01048 | 0.459 |
MOD_GlcNHglycan | 318 | 321 | PF01048 | 0.461 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.439 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.583 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.504 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.402 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.377 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.511 |
MOD_GSK3_1 | 289 | 296 | PF00069 | 0.542 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.490 |
MOD_GSK3_1 | 98 | 105 | PF00069 | 0.526 |
MOD_N-GLC_1 | 116 | 121 | PF02516 | 0.547 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.598 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.386 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.405 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.480 |
MOD_NEK2_2 | 130 | 135 | PF00069 | 0.320 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.450 |
MOD_PIKK_1 | 225 | 231 | PF00454 | 0.473 |
MOD_PIKK_1 | 37 | 43 | PF00454 | 0.520 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.699 |
MOD_PKA_2 | 259 | 265 | PF00069 | 0.436 |
MOD_Plk_1 | 180 | 186 | PF00069 | 0.494 |
MOD_Plk_1 | 263 | 269 | PF00069 | 0.446 |
MOD_Plk_2-3 | 159 | 165 | PF00069 | 0.614 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.442 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.492 |
MOD_ProDKin_1 | 241 | 247 | PF00069 | 0.558 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.692 |
MOD_SUMO_rev_2 | 204 | 211 | PF00179 | 0.660 |
TRG_DiLeu_BaEn_1 | 264 | 269 | PF01217 | 0.386 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.449 |
TRG_ER_diArg_1 | 211 | 213 | PF00400 | 0.615 |
TRG_Pf-PMV_PEXEL_1 | 200 | 204 | PF00026 | 0.725 |
TRG_Pf-PMV_PEXEL_1 | 276 | 281 | PF00026 | 0.514 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IA55 | Leptomonas seymouri | 51% | 75% |
A0A3Q8IQE0 | Leishmania donovani | 88% | 71% |
A4HGA7 | Leishmania braziliensis | 76% | 100% |
A4I3E1 | Leishmania infantum | 88% | 100% |
Q4Q8K3 | Leishmania major | 86% | 100% |